DK217188D0 - Farmaceutisk praeparat til behandling af neurologiske sygdomme - Google Patents

Farmaceutisk praeparat til behandling af neurologiske sygdomme

Info

Publication number
DK217188D0
DK217188D0 DK217188A DK217188A DK217188D0 DK 217188 D0 DK217188 D0 DK 217188D0 DK 217188 A DK217188 A DK 217188A DK 217188 A DK217188 A DK 217188A DK 217188 D0 DK217188 D0 DK 217188D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
neurological diseases
treating neurological
treating
diseases
Prior art date
Application number
DK217188A
Other languages
English (en)
Other versions
DK217188A (da
Inventor
Anders Hamberger
Nico M Van Gelder
Original Assignee
Anders Hamberger
Nico M Van Gelder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Hamberger, Nico M Van Gelder filed Critical Anders Hamberger
Publication of DK217188D0 publication Critical patent/DK217188D0/da
Publication of DK217188A publication Critical patent/DK217188A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK217188A 1987-04-22 1988-04-21 Farmaceutisk praeparat til behandling af neurologiske sygdomme DK217188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701662A SE8701662L (sv) 1987-04-22 1987-04-22 Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna

Publications (2)

Publication Number Publication Date
DK217188D0 true DK217188D0 (da) 1988-04-21
DK217188A DK217188A (da) 1988-10-23

Family

ID=20368273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217188A DK217188A (da) 1987-04-22 1988-04-21 Farmaceutisk praeparat til behandling af neurologiske sygdomme

Country Status (8)

Country Link
US (1) US4962121A (da)
EP (1) EP0288447A1 (da)
JP (1) JPS63313726A (da)
AU (1) AU606413B2 (da)
DE (1) DE288447T1 (da)
DK (1) DK217188A (da)
FI (1) FI881876A (da)
SE (1) SE8701662L (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3162709B2 (ja) * 1992-01-10 2001-05-08 アレクセエフナ コミッサロバ，イリナ 抗ストレス、ストレス予防性及び向神経性作用の医薬調製物
US6775531B1 (en) * 1994-07-21 2004-08-10 Interdigital Technology Corporation Subscriber terminal temperature regulation
US6099869A (en) * 1995-04-18 2000-08-08 Nutrition 21 Calcium taurate and antihypertensive drug for hypertension
US6348495B1 (en) * 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
EP0957928A1 (fr) * 1997-03-03 1999-11-24 Laboratoires Remilea Compositions d'extraits de plantes, leur procede de preparation, et compositions pharmaceutiques les renfermant
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
DE19735126C1 (de) * 1997-08-13 1999-01-21 Infectopharm Arzneimittel Und Verfahren zur Herstellung einer eine Zinkverbindung enthaltenden oralen Zusammensetzung und deren Verwendung zur Behandlung von Erkältungskrankheiten
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AT407991B (de) * 1998-11-10 2001-07-25 Red Bull Gmbh Mittel zum beeinflussen des transportes von substanzen aus pro- und eukariotischen zellen oder in solche zellen
ATE298205T1 (de) * 1999-01-29 2005-07-15 Sportmedizin Team Vertriebs Gm Zusammensetzung zur leistungsförderung bei sportlicher tätigkeit, ihre herstellung und verwendung als diätetisches lebensmittel
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
CA2383252A1 (en) 1999-08-24 2001-03-01 Medicure International Inc. Treatment of cardiovascular related pathologies
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
JP2004502757A (ja) 2000-07-07 2004-01-29 メディキュア　インターナショナル　インコーポレイテッド ピリドキシンおよびピリドキサール類縁体：心血管系治療薬
US6465517B1 (en) * 2000-07-11 2002-10-15 N.V. Nutricia Composition for the treatment of migraine
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
EP1773370A1 (en) * 2004-07-07 2007-04-18 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2008517956A (ja) * 2004-10-28 2008-05-29 メディキュア・インターナショナル・インコーポレーテッド 二重の抗血小板性／抗凝固性ピリドキシン類似体
EP2667711A4 (en) * 2011-01-26 2014-11-12 Nico Worldwide Inc MEANS FOR THE TREATMENT OF MIGRAINE
JP6265908B2 (ja) 2011-11-21 2018-01-24 ザ インスティチュート フォー エスノメディシン 神経変性疾患および障害を処置するためのｌ−セリン組成物、方法および使用
DE102012110009A1 (de) * 2012-10-19 2014-04-24 Thomas Gniech Mittel zur Linderung oder gegen Migräneschmerzen
GB201709459D0 (en) * 2017-06-14 2017-07-26 Intrabio Ltd Treatment for migraine

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3189M (fr) * 1963-07-13 1965-03-15 Pharmaco Biolog Soc Médicament a base d'acide 2-amino-éthanesulfonique.
FR5955M (da) * 1966-11-08 1968-04-16
DE2502735B2 (de) * 1975-01-23 1978-11-23 J. Pfrimmer & Co, 8520 Erlangen Verwendung von Glycerophosphaten
US4303692A (en) * 1978-11-22 1981-12-01 Gaull Gerald E Infant milk formula
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
US4439452A (en) * 1979-02-14 1984-03-27 Seymour Enrenpreis Class of analgesics and/or anti-inflammatory agents consisting of inhibitors of breakdown of endogenous enkephalin and/or endorphin, and combinations of said analgesics with antipyretic, anti-inflammatory (aspirin-type) drugs
DE2921852A1 (de) * 1979-05-29 1980-12-11 Fresenius Chem Pharm Ind Lipide senkendes mittel
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
IE55320B1 (en) * 1983-06-16 1990-08-01 Farley Health Products Infant foods
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4629625A (en) * 1984-08-29 1986-12-16 Gaull Gerald E Human nutritional compositions containing taurine and vitamins and/or minerals
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training

Also Published As

Publication number Publication date
US4962121A (en) 1990-10-09
SE8701662D0 (sv) 1987-04-22
EP0288447A1 (en) 1988-10-26
AU1505788A (en) 1988-10-27
JPS63313726A (ja) 1988-12-21
FI881876A (fi) 1988-10-23
SE8701662L (sv) 1988-10-23
FI881876A0 (fi) 1988-04-21
DK217188A (da) 1988-10-23
AU606413B2 (en) 1991-02-07
DE288447T1 (de) 1989-02-16

Similar Documents

Publication Publication Date Title
DK217188A (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK89090D0 (da) Farmaceutisk praeparat
DK545088A (da) Doseringsform til behandling af kardiovaskulaere sygdomme
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
IS3339A7 (is) Ný efnablanda lyfja
IS1667B (is) Hliðstæð aðferð við framleiðslu á meðferðarvirkumbis-aza-bísýklískum efnasamböndum
DK705488A (da) Farmaceutisk praeparat
KR890004737A (ko) 질병 치료용 자석
DK139388D0 (da) Farmaceutisk praeparat
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
DK675489D0 (da) Anvendelse af tpa-varianter til fremstilling af et terapeutisk praeparat til behandling af vaskulaere sygdomme
DK10188A (da) Middel til behandling af virussygdomme
DK276288D0 (da) Farmaceutisk praeparat
DK143488A (da) Laegemiddel til behandling af cancer
DK500589A (da) Farmaceutisk praeparat til behandling af lungeobstruktioner
DK637389A (da) Plantebehandlingspraeparat
DK441987A (da) Farmaceutisk praeparat til behandling af cerebral ischaemi
DK72288A (da) Farmaceutisk praeparat til behandling af ulcerativ tyktarmssygdom
DK511488D0 (da) Apparat til behandling af gummesygdomme
DK138888A (da) Farmaceutisk praeparat
DK639088D0 (da) Laegemiddel til behandling af iskaemiske hjertesygdomme
DK681288A (da) Aenootropt terapeutisk laegemiddelae
DK469487D0 (da) Laegemiddel til behandling af fedme